Participants 144 235 6
patients with active rheumatoid arthritis and an inadequate response to methotrexate alone.
Participants 377 533 4
active rheumatoid arthritis (RA) in patients receiving a stable background regimen of methotrexate (MTX) who have an inadequate response to MTX monotherapy.
Participants 590 639 6
patients with active RA (n = 507) were randomized
Participants 1957 2031 4
ION In patients with active RA in whom the response to MTX has been inadeq
